REG - Dechra Pharmaceutcls - Total Voting Rights

Dechra PharmaceuticalsAnnouncement

03/05/2022 10:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220503:nRSC0885Ka&default-theme=true

RNS Number : 0885K  Dechra Pharmaceuticals PLC  03 May 2022

 

3 May 2022

 

Dechra(®) Pharmaceuticals PLC

(Dechra or the Company)

LEI: 213800J4UVB5OWG8VX82

 

Total Voting Rights

 

 

In conformity with DTR 5.6.1R, the Company notifies the market of the
following:

 

As at the date of this announcement, the Company's issued share capital
consists of 108,389,445 ordinary shares with a nominal value of 1 pence each
(Ordinary Shares), with voting rights.  The Company does not hold any
Ordinary Shares in Treasury.

 

Therefore, the total number of Ordinary Shares with voting rights is
108,389,445.

 

The above figure of 108,389,445 Ordinary Shares may be used by shareholders in
the Company as the denominator for the calculations by which they will
determine if they are required to notify their interest in, or a change in
their interest in, the share capital of the Company under the FCA's Disclosure
and Transparency Rules.

 

 

For further information, please contact:

Dechra Pharmaceuticals PLC

Telephone number:  +44 (0) 1606 814730

Email: corporate.enquiries@dechra.com (mailto:corporate.enquiries@dechra.com)

 

 

About Dechra

Dechra is a global veterinary pharmaceuticals and related products business.
Our expertise is in the development, manufacture, marketing and sales of high
quality products exclusively for veterinarians worldwide. The majority of
Dechra's products are focused on key therapeutic categories where we have
leading market positions, and many of our products are used to treat medical
conditions for which there is no other effective solution or have a clinical
or dosing advantage over competitor products.  For more information, please
visit: www.dechra.com (http://www.dechra.com) .

 

Trademarks

Trademarks appear throughout this document in italics.  Dechra and the Dechra
"D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  TVREAPSDELPAEEA